BioSpace News Archive

HLA Typing for Transplant Market To Reach USD 1,206.02 Million By 2028, Says Reports And Data

Increasing application of HLA typing in disease diagnosis, increasing number of organ transplantation procedures performed globally, and rising prevalence of chronic diseases are key factors driving market growth.

January 14, 2022
·
8 min read
Microbial and Bacterial Cellulose Production Market To Reach USD 980.9 Million By 2028, Says Reports And Data

Favorable funding from private as well as public firms, increasing end-use applications in biomedical field, and increasing R&D investments in the healthcare sector are likely to fuel the market growth.

January 14, 2022
·
7 min read
Increasing Adoption of Tracking Devices in Hospitals and Introduction of Hands-free Medical Alert Systems to Drive Revenue Growth of the Market: Reports and Data

Technological advancements in alert systems, improving healthcare infrastructure, and rising preference towards personal health monitoring systems are some key factors expected to drive market growth.

January 14, 2022
·
8 min read
Spatial Genomics & Transcriptomics Market To Reach USD 675.34 Million By 2028, Says Reports And Data

Technological advancements in sequencing technologies, increasing application of spatial genomics and transcriptomics in biomarker identification and drug discovery, and increasing funding to expand R&D activities are key factors driving revenue growth of market.

January 14, 2022
·
9 min read
Global Rare Disease Drug Market Size Clinical Trials Insight 2028

Rare disease is disorder which affects a small percentage of total population. In last few years, there has been increased interest among pharmaceutical companies for the development of novel orphan drugs against rare diseases.

January 14, 2022
·
4 min read
Biotech Bay

VastBiome Announces Large Exploratory Prospective Data Collection to Understand Basic Science of the Microbiome and Immune Checkpoint Inhibitor Therapy

VastBiome is announcing sponsorship of an observational clinical study designed to collect data to understand molecular associations between immune checkpoint inhibitor (ICI) therapy and the gut microbiome (the collection of bacteria and other bugs living in the gastrointestinal tract).

January 14, 2022
·
2 min read
FDA

U.S. FDA Approves RINVOQ® (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults and children 12 years of age and older whose disease did not respond to previous treatment and is not well controlled with other pills or injections, including biologic medicines, or when use of other pills or injections is not recommended.

January 14, 2022
·
20 min read
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin

China SXT Pharmaceuticals, Inc. announced today that it develops and commercializes the Kuihuapan After-Soaking-Oral TCMP and Zhudanfen Directly-Oral TCMP products.

January 14, 2022
·
5 min read
BioMidwest

Largest Study to Date on COVID19 Pregnancy Outcomes Published in American Journal of Obstetrics and Gynecology

Newly published in the American Journal of Obstetrics and Gynecology is the largest study performed thus far on the effect of the COVID19 virus in pregnancy.

January 14, 2022
·
3 min read
FDA

U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

U.S. FDA Approves Pfizer’s CIBINQO ® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis.

January 14, 2022
·
19 min read